Results 141 to 150 of about 938,592 (268)

HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam. [PDF]

open access: yesDiagnostics (Basel), 2023
Nhu QBT   +19 more
europepmc   +1 more source

Tükürükten ayrıştırılan HCV antikorları ile Serum HCV-RNA arasındaki korelasyonun belirlenmesi

open access: yes, 2009
Amaç: Tükürükte Hepatit C virusuna(HCV) karşı bulunan antikorlar ile kandaki HCV-RNA ve antikorları arasındaki ilişkiyi araştırmak ve epidemiyolojik çalışmalar ön planda olmak üzere saha çalışmalarında bu yöntemin kullanılabilirliğini saptamaktır.Gereç ...
OYA ÖZLEM EREN KUTSOYLU
core  

Non–AIDS‐Defining Cancer Incidence in People With HIV in Milan, Italy, 2000–2023: Temporal Trends and Comparison With the General Population

open access: yesInternational Journal of Cancer, Volume 159, Issue 12, Page 2870-2876, 15 December 2026.
ABSTRACT People with HIV (PWH) are living longer, but contemporary data on non–AIDS‐defining cancers (NADCs) in Italy remain limited. We assessed incident cancers in a retrospective cohort of PWH in Milan, Italy, between January 2000 and December 2023. Follow‐up was grouped into 2000–2007, 2008–2015, and 2016–2023. Incidence rates (IRs) were calculated
Giacomo Pozza   +14 more
wiley   +1 more source

Dynamic Changes in Metabolic Syndrome and Risk of Hepatocellular Carcinoma: Evidence From a Nationwide Japanese Cohort

open access: yesLiver International Communications, Volume 7, Issue 4, December 2026.
ABSTRACT Aim Metabolic syndrome (MetS) is a known risk factor for hepatocellular carcinoma (HCC), but the impact of cumulative MetS burden and changes in MetS status over time remains unclear. This study aimed to assess these associations using a large‐scale Japanese health dataset.
Yutaka Yata   +9 more
wiley   +1 more source

An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA. [PDF]

open access: yesPLoS One, 2023
Hansoongnern P   +9 more
europepmc   +1 more source

A Confirmatory, Dual Center Nonhuman Primate Study on the Efficacy of Novel Oropharyngeal Spray Immunization With an Adenoviral Vector Vaccine Against RSV—Important Lessons Learned

open access: yesJournal of Medical Primatology, Volume 55, Issue 6, December 2026.
ABSTRACT Background In a randomized, blinded, dual center study across two European primate research facilities, we evaluated the immunogenicity and protective efficacy of a DNA prime—oropharyngeal adenoviral boost vaccination strategy against respiratory syncytial virus (RSV).
Matthias Tenbusch   +15 more
wiley   +1 more source

Recognition of 7 genes signature (Cirrhosis Risk Score) in the diagnosed non-responders to DAAs therapy by intra-PBMCs nested HCV RNA PCR. [PDF]

open access: yesJ Genet Eng Biotechnol, 2023
Galal AGM   +5 more
europepmc   +1 more source

Anti‐Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH‐B Study

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Treatment indication for chronic hepatitis B (CHB) varies across clinical guidelines. This study evaluated treatment eligibility and uptake in a large Australian cohort of people with CHB. The REACH‐B study recruited people with CHB managed through a national network of healthcare services.
Behzad Hajarizadeh   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy